LPTX
Leap Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.77
−3.15%Institutional positioning
13F filings over the trailing two quarters
New 14Increased 9Reduced 6Sold out 42
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Unchanged | 2,342,174 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,818,414 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 1,217,553 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | New Position | 725,120 | May 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 571,068 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 297,086 | May 8, 2026 |
| CITADEL ADVISORS LLC | Increased | 252,100 | May 15, 2026 |
| UBS GROUP AG | Increased | 171,068 | May 5, 2026 |
| LPL FINANCIAL LLC | Increased | 162,494 | May 6, 2026 |
| STATE STREET CORP | Unchanged | 140,113 | May 15, 2026 |
| JANE STREET GROUP, LLC | Increased | 118,000 | May 12, 2026 |
| GROUP ONE TRADING, L.P. | Reduced | 107,416 | May 13, 2026 |
| TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC | Unchanged | 104,200 | May 11, 2026 |
| KEY CLIENT FIDUCIARY ADVISORS, LLC | Increased | 91,424 | Apr 9, 2026 |
| NORTHERN TRUST CORP | Unchanged | 87,562 | May 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings